Immunoglobulins: Global Market Outlook

Immunoglobulins: Global Market Outlook

Report Scope:

The scope of this study encompasses the current and forecast markets for normal and hyper immunoglobulins. The report segments markets based on product type and route of administration. The report surveys the competitive landscape, market dynamics and current and developing technologies. The report also analyzes the impact of COVID-19 on the market.

In terms of geographical regions, the report analyzes the market across North America, Europe, Asia-Pacific and the rest of the world (RoW). Key regions such as the U.S., Canada, Europe (U.K., Italy, France and Germany), Asia-Pacific (China, India and Japan) are highlighted in the discussion.

The report also analyzes key companies and their recent developments, such as product launches, business expansions and collaborations.

Report Includes:

A brief general outlook of the global market for immunoglobulins

Analyses of the global market trends, with historic market revenue data (sales figures) for 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027

Estimation of the actual market size and revenue forecast for the global immunoglobulins market in USD million terms, and corresponding market share analysis by product type, route of administration, and region

In-depth information (facts and figures) concerning the major factors influencing the progress of this market (benefits, and industry-specific challenges) with respect to specific growth trends, upcoming technologies, current and future prospects in therapeutic treatments, and contributions to the overall market

Identification of major stakeholders and analysis of the company competitive landscape based on their recent developments, financial performance, segmental revenues, and operational integration

Company profiles of the market leading players

Companies Mentioned

ADMA BIOLOGICS INC.
BAXTER INTERNATIONAL
BIO PRODUCTS LABORATORY LTD.
CHINA BIOLOGIC PRODUCTS INC.
CSL LTD.
GRIFOLS INTERNATIONAL S.A.
INNOVATIVE RESEARCH
INTAS PHARMACEUTICALS LTD.
KEDRION SPA
LFB S.A.
OCTAPHARMA AG
SANQUIN
TAKEDA PHARMACEUTICAL COMPANY LIMITED.